AHC
Adell Harriman & Carpenter’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,174
| Closed | -$206K | – | 166 |
|
|
2024
Q1 | $206K | Sell |
2,174
-949
| -30% | -$90.1K | 0.02% | 162 |
|
|
2023
Q4 | $279K | Sell |
3,123
-584
| -16% | -$52.1K | 0.03% | 148 |
|
|
2023
Q3 | $271K | Buy |
3,707
+60
| +2% | +$4.38K | 0.03% | 147 |
|
|
2023
Q2 | $302K | Sell |
3,647
-510
| -12% | -$42.3K | 0.03% | 144 |
|
|
2023
Q1 | $317K | Sell |
4,157
-160
| -4% | -$12.2K | 0.03% | 146 |
|
|
2022
Q4 | $358K | Sell |
4,317
-3,564
| -45% | -$296K | 0.04% | 136 |
|
|
2022
Q3 | $625K | Sell |
7,881
-530
| -6% | -$42K | 0.08% | 118 |
|
|
2022
Q2 | $625K | Buy |
8,411
+990
| +13% | +$73.5K | 0.08% | 100 |
|
|
2022
Q1 | $667K | Sell |
7,421
-2,758
| -27% | -$248K | 0.06% | 122 |
|
|
2021
Q4 | $1.14M | Sell |
10,179
-435
| -4% | -$48.7K | 0.11% | 107 |
|
|
2021
Q3 | $1.33M | Sell |
10,614
-2,500
| -19% | -$314K | 0.14% | 103 |
|
|
2021
Q2 | $1.78M | Sell |
13,114
-65
| -0.5% | -$8.8K | 0.19% | 94 |
|
|
2021
Q1 | $1.79M | Sell |
13,179
-215
| -2% | -$29.2K | 0.22% | 88 |
|
|
2020
Q4 | $1.89M | Sell |
13,394
-555
| -4% | -$78.1K | 0.25% | 83 |
|
|
2020
Q3 | $1.55M | Sell |
13,949
-478
| -3% | -$53.3K | 0.23% | 78 |
|
|
2020
Q2 | $1.62M | Sell |
14,427
-805
| -5% | -$90.1K | 0.28% | 73 |
|
|
2020
Q1 | $1.18M | Buy |
15,232
+3,035
| +25% | +$235K | 0.25% | 78 |
|
|
2019
Q4 | $1.16M | Buy |
12,197
+2,338
| +24% | +$222K | 0.19% | 85 |
|
|
2019
Q3 | $752K | Buy |
9,859
+2,966
| +43% | +$226K | 0.14% | 96 |
|
|
2019
Q2 | $605K | Buy |
6,893
+1,598
| +30% | +$140K | 0.11% | 97 |
|
|
2019
Q1 | $479K | Buy |
5,295
+107
| +2% | +$9.69K | 0.09% | 104 |
|
|
2018
Q4 | $372K | Buy |
+5,188
| New | +$372K | 0.08% | 121 |
|